Lv41
614 积分 2020-08-12 加入
Efficacy and Safety of Ixekizumab in Chinese Patients With Moderate-to-Severe Plaque Psoriasis: 60-Week Results From a Phase 3 Study
8小时前
已完结
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
1个月前
已完结
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
《IASLC第九版肺癌TNM分期》解读
1个月前
已完结
Proposed Ninth Edition TNM Staging System for Lung Cancer: Guide for Radiologists
1个月前
已完结
银屑病关节炎药物治疗进展
1个月前
已完结
肿瘤相关静脉血栓栓塞症的防治新认识
2个月前
已完结
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
2个月前
已完结
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
2个月前
已完结
皖公网安备34019202002308
